Literature DB >> 15926781

Deaths associated with cysticercosis. Report of three cases and review of the literature.

Christopher M DeGiorgio1, Iceland Houston, Sandra Oviedo, Frank Sorvillo.   

Abstract

There is significant concern about an increased risk of death in patients with neurocysticercosis who receive antihelminthic agents. To clarify the risk factors for death associated with cysticercosis, the authors identified all cases of mortality over a 5-year period in patients in whom cysticercosis was diagnosed and who were discharged from a major metropolitan medical center. In addition, they reviewed the literature to delineate risk factors associated with cysticercosis-related death, concluding that the risk of death is highest in patients with heavy cyst burdens and those surgically treated for intracranial hypertension. Death is rare in properly selected patients with parenchymal disease in whom the cyst burden is low and intracranial hypertension is absent. The most common causes of death appear to be 1) intracranial hypertension in surgically treated patients and 2) shunt infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15926781     DOI: 10.3171/foc.2002.12.6.3

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  19 in total

1.  Neurocysticercosis.

Authors:  Christopher M DeGiorgio; Marco T Medina; Reyna Durón; Chi Zee; Susan Pietsch Escueta
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

2.  Cysticercosis of the fourth ventricle causing sudden death: a case report and review of the literature.

Authors:  Tibor Hortobágyi; Ali Alhakim; Olaf Biedrzycki; Vesna Djurovic; Jeewan Rawal; Safa Al-Sarraj
Journal:  Pathol Oncol Res       Date:  2008-09-18       Impact factor: 3.201

Review 3.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

Review 4.  Hydrocephalus in neurocysticercosis.

Authors:  Hamilton Matushita; Fernando Campos Gomes Pinto; Daniel Dante Cardeal; Manoel Jacobsen Teixeira
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

5.  Neurocysticercosis: an update.

Authors:  Christina M Coyle
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

6.  Transventricular neuroendoscopic excision of giant racemose subarachnoid cysticercosis.

Authors:  Carmina F Angeles; Dennis Vollmer; Aaron Mohanty
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

Review 7.  Update on eosinophilic meningoencephalitis and its clinical relevance.

Authors:  Carlos Graeff-Teixeira; Ana Cristina Arámburu da Silva; Kentaro Yoshimura
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

8.  Deaths from cysticercosis, United States.

Authors:  Frank J Sorvillo; Christopher DeGiorgio; Stephen H Waterman
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

9.  Mortality in Parenchymal and Subarachnoid Neurocysticercosis.

Authors:  Jesus Abanto; Daniel Blanco; Herbert Saavedra; Isidro Gonzales; Diego Siu; E Javier Pretell; Javier A Bustos; Hector H Garcia
Journal:  Am J Trop Med Hyg       Date:  2021-07-07       Impact factor: 3.707

10.  Anthelmintics for people with neurocysticercosis.

Authors:  Edward J M Monk; Katharine Abba; Lakshmi N Ranganathan
Journal:  Cochrane Database Syst Rev       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.